Stocks jump on $67B in tech, biotech M&A

equity markets rallied Monday amid optimism a COVID-19 vaccine will be distributed by yearend and amid a flurry of deals.” data-reactid=”17″U.S. equity markets rallied Monday amid optimism a COVID-19 vaccine will be distributed by yearend and amid a flurry of deals.

$40 billion cash and stock deal.” data-reactid=”18″The Nasdaq Composite traded up 2% as tech stocks continued to dictate the market’s direction after Nvidia agreed to purchase Arm Holdings from SoftBank Group in a $40 billion cash and stock deal.

The S&P 500, meanwhile, was higher by 1.4% after Gilead Sciences Inc. agreed to a $21 billion deal for Immunomedics Inc. and Verizon Communications Inc. announced a $6.25 billion deal to buy wireless phone reseller Tracfone from America Movil SAB. The Dow Jones Industrial Average gained 1.02%.

expand its late-stage trial to 44,000 participants, up from its initial target of 30,000.” data-reactid=”24″The early gains were also

Read More